2023 Q2 Form 10-Q Financial Statement

#000121465923006742 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $35.00K $45.00K $45.00K
YoY Change -25.53% 0.0% 73.08%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $81.00K $68.00K $80.00K
YoY Change 1.25% -15.0% 8.11%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.000K $3.000K $3.000K
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $95.00K $80.00K $92.00K
YoY Change 2.15% -13.04% 0.0%
Operating Profit -$60.00K -$35.00K -$47.00K
YoY Change 30.43% -25.53%
Interest Expense $54.00K $52.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net $54.00K $52.00K
YoY Change -70.65%
Pretax Income -$6.000K $17.00K $5.000K
YoY Change -104.35% 240.0% -93.67%
Income Tax
% Of Pretax Income
Net Earnings -$6.000K $17.00K $5.000K
YoY Change -104.35% 240.0% -93.67%
Net Earnings / Revenue -17.14% 37.78% 11.11%
Basic Earnings Per Share $0.01 $0.01
Diluted Earnings Per Share $0.01 $0.00 $974.30
COMMON SHARES
Basic Shares Outstanding 5.132M shares 5.132M shares 5.132K shares
Diluted Shares Outstanding 5.132K shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $432.0K $437.0K $254.0K
YoY Change 16.13% 72.05% 490.7%
Cash & Equivalents $432.0K $437.0K $254.0K
Short-Term Investments
Other Short-Term Assets $45.00K $62.00K $38.00K
YoY Change 4.65% 63.16% -82.73%
Inventory
Prepaid Expenses
Receivables $22.00K
Other Receivables $3.542M
Total Short-Term Assets $4.019M $4.041M $3.856M
YoY Change 1.57% 4.8% -1.1%
LONG-TERM ASSETS
Property, Plant & Equipment $625.0K $628.0K $640.0K
YoY Change -1.88% -1.88% -1.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $625.0K $628.0K $640.0K
YoY Change -1.88% -1.88% -19.8%
TOTAL ASSETS
Total Short-Term Assets $4.019M $4.041M $3.856M
Total Long-Term Assets $625.0K $628.0K $640.0K
Total Assets $4.644M $4.669M $4.496M
YoY Change 1.09% 3.85% -4.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.00K $55.00K $66.00K
YoY Change 5.26% -16.67% 135.71%
Accrued Expenses $37.00K $21.00K $22.00K
YoY Change 0.0% -4.55% 22.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $57.00K $76.00K $96.00K
YoY Change 1.79% -20.83% -46.07%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $57.00K $76.00K $96.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $57.00K $76.00K $96.00K
YoY Change 1.79% -20.83% -67.24%
SHAREHOLDERS EQUITY
Retained Earnings -$59.04M -$59.04M
YoY Change -0.08%
Common Stock $51.00K $51.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.587M $4.593M $4.400M
YoY Change
Total Liabilities & Shareholders Equity $4.644M $4.669M $4.496M
YoY Change 1.09% 3.85% -4.28%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.000K $17.00K $5.000K
YoY Change -104.35% 240.0% -93.67%
Depreciation, Depletion And Amortization $3.000K $3.000K $3.000K
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities -$5.000K $1.000K $2.000K
YoY Change -104.24% -50.0% -92.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -5.000K $1.000K 2.000K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -5.000K $1.000K $0.00
YoY Change -104.24% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$5.000K $1.000K $2.000K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000105744
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-08187
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
NEW CONCEPT ENERGY, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2399477
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1603 LBJ Freeway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75234
CY2023Q1 dei City Area Code
CityAreaCode
(972)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
407-8400
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
CY2023Q1 dei Trading Symbol
TradingSymbol
GBR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5131934 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
437000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436000 usd
CY2023Q1 GBR Note Receivable And Accrued Interest From Related Party
NoteReceivableAndAccruedInterestFromRelatedParty
3542000 usd
CY2022Q4 GBR Note Receivable And Accrued Interest From Related Party
NoteReceivableAndAccruedInterestFromRelatedParty
3542000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
62000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
30000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4041000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4008000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
628000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
631000 usd
CY2023Q1 us-gaap Assets
Assets
4669000 usd
CY2022Q4 us-gaap Assets
Assets
4639000 usd
CY2023Q1 GBR Due To Related Parties
DueToRelatedParties
8000 usd
CY2022Q4 GBR Due To Related Parties
DueToRelatedParties
8000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
55000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
23000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
76000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5131934 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5131934 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5131934 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5131934 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
51000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
51000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63579000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63579000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59038000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59055000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4593000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4576000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4669000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4639000 usd
CY2023Q1 us-gaap Revenues
Revenues
45000 usd
CY2022Q1 us-gaap Revenues
Revenues
45000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
12000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
12000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
80000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
92000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-35000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-47000 usd
CY2023Q1 GBR Interest Income From Relatedparty
InterestIncomeFromRelatedparty
52000 usd
CY2022Q1 GBR Interest Income From Relatedparty
InterestIncomeFromRelatedparty
52000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5000 usd
CY2023Q1 GBR Net Income Loss Per Common Sharebasic And Diluted
NetIncomeLossPerCommonSharebasicAndDiluted
0.01
CY2022Q1 GBR Net Income Loss Per Common Sharebasic And Diluted
NetIncomeLossPerCommonSharebasicAndDiluted
0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5132 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5132 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
17000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000 usd
CY2022Q1 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-18000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
32000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
60000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
13000 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
36000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
252000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
437000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
254000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4576000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
17000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4593000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4395000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
5000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4400000 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80C_eus-gaap--NatureOfOperations_zYV22SAuECah" style="font: 10pt Times New Roman; margin: 0pt 0"><b>NOTE B: <span id="xdx_82D_zvfcWzjXtBwd">NATURE OF OPERATIONS</span></b></p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0; text-indent: 20pt">The Company owns approximately 190 acres of land located in Parkersburg West Virginia. Located on the land are four structures totaling approximately 53,000 square feet. Of this total area the main industrial/office building contains approximately 24,800 square feet of which approximately 16,000 square feet is leased at a rate of <span id="xdx_90B_ecustom--LeaseRevenueperAnnum_c20230101__20230331_zrxNaie7fVdg" title="Lease revenue per annum">$101,000 per annum</span>.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman; margin: 0pt 0">In August 2020, the Company sold its oil and gas operations to a third party. On January 1, 2022, the Company entered into a Consulting Management Agreement with respect to such oil and gas operations whereby the Company would provide management, supervisory and administrative services for a fee of 10% of the gross revenue of such oil and gas operations. The agreement is effective January 1, 2022 and may be terminated by either party upon sixty days’ notice.</p> <p style="font: 10pt Times New Roman; margin: 0pt 0"> </p>
CY2023Q1 GBR Lease Revenueper Annum
LeaseRevenueperAnnum
$101,000 per annum
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000000 usd

Files In Submission

Name View Source Status
0001214659-23-006742-index-headers.html Edgar Link pending
0001214659-23-006742-index.html Edgar Link pending
0001214659-23-006742.txt Edgar Link pending
0001214659-23-006742-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g5923010q.htm Edgar Link pending
gbr-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gbr-20230331_cal.xml Edgar Link unprocessable
gbr-20230331_def.xml Edgar Link unprocessable
gbr-20230331_lab.xml Edgar Link unprocessable
gbr-20230331_pre.xml Edgar Link unprocessable
g5923010q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending